Fatal Case of Pneumocystis Jirovecii Pneumonia (PJP) During Treatment for Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome
Chaoe Zhou,Jun Li,Fude Zhou,Lei Huang,Xinmin Liu,Haichao Li
DOI: https://doi.org/10.2147/idr.s447694
2024-01-17
Infection and Drug Resistance
Abstract:Chaoe Zhou, 1, &ast Jun Li, 2, &ast Fude Zhou, 3 Lei Huang, 4 Xinmin Liu, 1 Haichao Li 5 1 Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, Beijing, People's Republic of China; 3 Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People's Republic of China; 4 Department of Clinical Laboratory, Peking University First Hospital, Beijing, People's Republic of China; 5 Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xinmin Liu, Department of Geriatrics, Peking University First Hospital, Tel +86-10-8357-2128, Beijing, 100034, People's Republic of China, Email Haichao Li, Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Tel +86-10-8357-2128, Beijing, 100034, People's Republic of China, Email Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is an acute, rare and potentially fatal drug reaction. To date, limited studies have reported secondary Pneumocystis jirovecii pneumonia (PJP) infection during the treatment of DRESS syndrome. A 53-year-old man was admitted to the hospital due to a persistent fever lasting for 5 days. He had a medical history of hypertension, psoriasis, urticaria, and had recently been treated with carbamazepine for nerve spasm two weeks ago. After admission, the patient presented with a high fever accompanied by chills, abdominal pain, bilateral upper limb muscle pain, and generalized lymph nodes enlargement. Laboratory tests revealed elevated eosinophils and atypical lymphocytes. Subsequently, the patient developed multiple internal organ complications, including oliguria, elevated serum creatinine, liver enzymes, and cardiac troponin I. Based on diagnostic criteria, the patient was diagnosed with DRESS syndrome. To manage the DRESS syndrome, the patient was successively or simultaneously prescribed methylprednisolone, cyclosporin and intravenous immunoglobulin, resulting in an improvement of the condition. However, during the treatment, the patient was infected with Pneumocystis jirovecii . Despite targeted therapy with trimethoprim/sulfamethoxazole, primaquine and clindamycin successively, no remission was observed. Chest CT scans exhibited multiple exudations in both lungs, indicative of interstitial pneumonia. Unfortunately, the patient's oxygenation progressively declined, leading to his untimely demise. This rare case further highlights the need for clinicians to be aware of the risk of Pneumocystis jirovecii infection in DRESS syndrome patients treated with long-term and high-dose glucocorticoid therapy. Keywords: DRESS syndrome, Pneumocystis jirovecii pneumonia, carbamazepine, glucocorticoid therapy, case report The Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare, complex, and potentially life-threatening hypersensitivity reaction caused by certain drugs. It typically manifests with a skin rash, fever, facial edema, hematologic abnormalities (elevated eosinophils and/or presence of atypical lymphocytes), lymphadenopathy, and multiple organ dysfunction in severe cases. Its incidence ranges from 1:1000 to 1:10,000 people, with a mortality rate as high as 10%. 1 In DRESS syndrome, visceral organs are involved in nearly 90% of patients, and in about half of patients' multiple organs may be involved, most commonly affecting the liver, kidneys, and lungs. The involvement of visceral organs is directly associated with mortality. 2 The liver is the most frequently affected visceral organ in DRESS syndrome (75% of cases), hepatitis of varying severity is often seen, often with elevated levels of liver transaminases, alkaline phosphatase, and creatinine. The kidneys are also commonly affected in DRESS syndrome (10 to 30% of cases). 3 Acute kidney injury was observed in 96% patients, 4% patients had isolated proteinuria and hematuria without acute kidney injury, oliguria and anuria were reported in 18% and 6% patients, respectively. 4 Although lung involvement in DRESS syndrome is less common (5 to 25% of cases), it is associated with a more severe clinical course and potentially worse outcomes. DRESS involvement in the lungs can manifest in a variety of manifestations, ranging from mild cough or dyspnea with chest imaging nonspecific interstitial changes to acute respiratory distress syndrome with life-threatening hypoxic respiratory failure. Symptoms of cough -Abstract Truncated-
pharmacology & pharmacy,infectious diseases